INT J ENV RES PUB HE

投稿咨询

官方网站：http://www.journals.elsevier.com/current-opinion-in-cell-biology/

投稿网址：https://www.evise.com/evise/faces/pages/login/login.jspx?resourceUrl=%2Ffaces%2Fpages%2Fnavigation%2FNavController.jspx%3FJRNL_ACR%3DCOCEBI%26

PMC链接：http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0955-0674%5BISSN%5D

细胞生物学(COCEBI)发表权威、全面和系统的评论。COCEBI帮助专家对当前先进的细胞生物学进行清晰和可读的合成，以保持最新的进展。专家作者从今天出版的大量信息中注释最有趣的论文，节省了宝贵的时间，并让读者了解重要的领域。《细胞生物学当前观点》是《细胞生物学当前观点与研究》(CO+RE)系列期刊的一部分，是《细胞生物学当前研究》(CRCBIO)最新一期期刊《开放获取期刊》(open access journal, Current Research in Cell Biology, CRCBIO)的配套期刊。CO+RE期刊利用了当前的观点遗产——卓越的编辑、高影响力和全球影响力——确保它们是广泛阅读的资源，是科学家工作流程不可或缺的一部分。细胞生物学的最新观点为研究人员、讲师、教师、专业人士、决策者和学生提供了宝贵的信息来源。细胞生物学分为六个主题部分，每个部分每年复习一次。主题包括单元结构;细胞信号传导;细胞核;膜贩运;细胞动力学;细胞分化和疾病。该杂志建立在爱思唯尔卓越的科学出版声誉和长期致力于传播可复制的生物医学研究，旨在改善人类健康。

Current Opinion in Cell Biology (COCEBI) publishes authoritative, comprehensive, and systematic reviews. COCEBI helps specialists keep up to date with a clear and readable synthesis on current advances cell biology. Expert authors annotate the most interesting papers from the expanding volume of information published today, saving valuable time and giving the reader insight on areas of importance.Current Opinion in Cell Biology is part of the Current Opinion and Research (CO+RE) suite of journals and is a companion to the new primary research, open access journal, Current Research in Cell Biology (CRCBIO). CO+RE journals leverage the Current Opinion legacy—of editorial excellence, high-impact, and global reach—to ensure they are a widely read resource that is integral to scientists’ workflow.Current Opinion in Cell Biology serves as an invaluable source of information for researchers, lecturers, teachers, professionals, policy makers and students. The subject of cell biology is divided into six themed sections, each of which is reviewed once a year. Themes include cell architecture; cell signaling; cell nucleus; membrane trafficking; cell dynamics; and cell differentiation and disease.The journal builds on Elsevier’s reputation for excellence in scientific publishing and long-standing commitment to communicating reproducible biomedical research targeted at improving human health.